Prognostic Nomogram and Predictive Factors in Refractory or Relapsed Diffuse Large B-Cell Lymphoma Patients Failing Front-Line R-CHOP Regimens

Background: The clinical course of relapsed or refractory (r/r) diffuse large B-cell lymphoma (DLBCL) is variable, with limited efficacy data of second-line treatment in a post-rituximab real-world context. Hence, we explored the predictors and constructed a nomogram for risk stratification in this...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Shiyu, Qin, Yan, Liu, Peng, Yang, Jianliang, Yang, Sheng, He, Xiaohui, Zhou, Shengyu, Gui, Lin, Zhang, Changgong, Zhou, Liqiang, Sun, Yan, Shi, Yuankai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995391/
https://www.ncbi.nlm.nih.gov/pubmed/32047558
http://dx.doi.org/10.7150/jca.36997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995391/
https://www.ncbi.nlm.nih.gov/pubmed/32047558
http://dx.doi.org/10.7150/jca.36997

Ejemplares similares